Indication

Lymphoblastic lymphoma

Lymphoblastic lymphoma is an aggressive, high-grade non-Hodgkin lymphoma characterized by the malignant proliferation of immature lymphoid precursor cells, known as lymphoblasts. Read more about Lymphoblastic lymphoma

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Lymphoblastic lymphoma therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Lymphoblastic lymphoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Lymphoblastic lymphoma.

Lymphoblastic lymphoma is an aggressive, high-grade non-Hodgkin lymphoma characterized by the malignant proliferation of immature lymphoid precursor cells, known as lymphoblasts.

Arising from either T-cell or B-cell lineages, it predominantly involves the lymphatic and hematopoietic systems, most frequently affecting children, adolescents, and young adults with a male predominance.

It is biologically continuous with acute lymphoblastic leukemia, with T-cell lymphoblastic lymphoma frequently presenting as an anterior mediastinal mass with lymphadenopathy, and B-cell subtypes more commonly demonstrating peripheral nodal, cutaneous, or bony involvement with minimal or absent bone marrow and peripheral blood infiltration at diagnosis.

Personalize your experience

Follow Lymphoblastic lymphoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it